HEALTH OF WOMAN. 2015.9(105):101–106; doi 10.15574/HW.2015.105.101 

Андрогенозалежна алопеція у жінок: клінічний погляд на проблему 

Веропотвелян П. М., Веропотвелян М. П., Цехмістренко І. С., Журавльова С. А., Гужевська І. В.

«Межобластной центр медицинской генетики и пренатальной диагностики», г. Кривой Рог

Перинатальный центр, г. Киев

Национальный медицинский университет им. А.А. Богомольца, г. Киев 

У статті розглянуто андрогенозалежну алопецію, яка негативно впливає на самооцінку, психологічне благополуччя і якість життя, особливо у жінок порівняно з чоловіками.

У роботі висвітлюється етіологія, патогенез, питання діагностики та лікування андрогензалежних алопеції у жінок. 

Ключові слова: алопеція, гіперандрогенія. 

Література:

1. Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI et al. 2011. European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J. Dtsch. Dermatol. Ges. 9(6):S1–57.

2. Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W et al. 2000. Lack of efficacy of finasteride in postmenopausal women with androgetic alopecia. J. Am. Acad. Dermatol. 43(5;1):768–76.

3. Peereboom-Wynia JD, van der Willigen AH, van Joost T, Stolz E. 1989. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia infemales. Acta Derm. Venereol. 69(5):395–8.

4. Vexiau P, Chaspoux C, Boudou P, Fiet J, Jouanique C, Hardy N, Reygagne P. 2002. Effects of minoxidil 2% vs. cyproterone acetate treatment on female alopecia: acontrolled, 12-month randomized trial. Br. J. Dermatol. 146(6):992–9.

5. Carmina E, Lobo RA. 2003. Treatment of hyperandrogenic alopecia in women. Fertil. Steril. 79(1):91–5. http://dx.doi.org/10.1016/S0015-0282(02)04551-X

6. Sinclair R, Wewerinke M, Jolley D. 2005. Treatment of female pattern hair loss with oral antiandrogens. Br. J. Dermatol. 152(3):466–73.

7. Azziz R, Carmina E, Sawaya ME. 2000. Idiopathic hirsutism. Endocr. Rev. 21(4):347–62.

8. Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J. 1999. Patient perceived importance of negative effects of androgenetic alopecia in women. J. Womens Health Gend. Based Med. 8:1091–5. http://dx.doi.org/10.1089/jwh.1.1999.8.1091; PMid:10565667

9. Grodnitskaya ЕЕ, Kurtser МА. 2014. Androgen-dependent alopecia in women: pathogenesis, clinical fpresentation, diagnosis, treatment. Obstetrics and Gynecology 11:12–16.

10. Thiedke CC. 2003. Alopecia in women. Am. Fam. Physician. 67(5):1007–14.

11. Dinh QQ, Sinclair R. 2007. Female pattern hair loss: current treatment concepts. Clin. Interv. Aging. 2(2):189–99.

12. Ludwig E. 1977. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br. J. Dermatol. 97:247–54. http://dx.doi.org/10.1111/j.1365-2133.1977.tb15179.x; PMid:921894

13. Olsen EA. 1999. The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women. J. Am. Acad. Dermatol. 40:106–9. http://dx.doi.org/10.1016/S0190-9622(99)70539-6

14. Gan DC, Sinclair RD. 2005. Prevalence of male and female pattern hair loss in Maryborough. J. Investig. Dermatol. Symp. Proc. 10:184–9. http://dx.doi.org/10.1111/j.1087-0024.2005.10102.x; PMid:16382660

15. Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M et al. 2011. European Consensus Group. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br. J. Dermatol. 164(1):5–15.

16. Futterweit W, Dunaif A, Yeh HC, Kingsley P. 1988. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J. Am. Acad. Dermatol. 19(5;1):831–6.

17. Carmina E, Rosato F, Jannм A, Rizzo M, Longo RA. 2006. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J. Clin. Endocrinol. Metab. 91(1):2–6.

18. Cousen P, Messenger A. 2010. Female pattern hair loss in complete androgen insensitivity syndrome. Br. J. Dermatol. 162(5):1135–7.

19. Vermeulen A, Verdonck L, Kaufman JM. 1999. A critical evaluation of simple methods for the estimation of free testosterone in Serum. J. Clin. Endocrinol. Metab. 84:3666–72. http://dx.doi.org/10.1210/jcem.84.10.6079; PMid:10523012

20. Whiting DA, Jacobson C. 1992. Treatment of female androgenetic alopecia with minoxidil 2%. Int. J. Dermatol. 31(11):800–4.

21. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. 1999. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts inhorizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J. Investig. Dermatol. Symp. Proc. 4(3):282–4.

22. Shum KW, Cullen DR, Messenger AG. 2002. Hair loss in women with hyperandrogenism: four cases responding to finasteride. J. Am. Acad. Dermatol. 47:733–9. http://dx.doi.org/10.1067/mjd.2002.124608; PMid:12399766

23. Trueb RM. 2004. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology 209:202–7. http://dx.doi.org/10.1159/000079890; PMid:15459533